5Myhr KM, Mellgren SI. Corticosteroids in the treatment of multiple sclerosis [ J ]. Acta Neurol Scand Suppl, 2009, (189) : 73 -80. 被引量：1
6Comi G,Hartung HP, Martinelli BF. Evidence for use of glatiramier acetate in multiple sclerosis [J]. Lancet Neuron, 2005, 4(2) : 75 -76. Discus- sion 76 -77. 被引量：1
7Paniteh H, Goodin DS, Franeis G, et al. Random- ized, comparative study of interferon beta la treatment regiments in MS: the Evidence Trial [J:. Neurology, 2002, 59(10): 1496-1506. 被引量：1
8McDonald Wl, Compston A, Edan G, et al. Rec- ommended diagnostic criteria for multiple sclero- sis: guidelines from international panel on the di- agnosis of multiple sclerosis [ J]. Ann Neurol, 2001 , 50(1) : 121 -127. 被引量：1
9Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an inter- national survey. National Multiple Sclerosis Socie- ty (USA)Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis [ J ]. Neurology, 1996,46(4) : 907 -911. 被引量：1
10Yokoyama H, Hiai S, Oura H, et al. Effects of to- tal of saponins extracted from several crude drugs on rat adrenocortical hormone secretion [J]. Yakugaku Zasshi,1982, 102(6) : 555 -559. 被引量：1
